Serum Leptin and 5-Hydroxytryptamine Measurements for the Diagnosis and Treatment of Premature Ejaculation - 27/11/13
, Kunlong TangAbstract |
Objective |
To study the significance of measurements of plasma leptin and 5-hydroxytryptamine (5-HT) levels in the diagnosis of premature ejaculation (PE).
Methods |
We compared plasma leptin and 5-HT levels, intravaginal ejaculation latency time (IELT) and Chinese Index of Premature Ejaculation-5 (CIPE-5) scores between 59 patients with PE and 64 healthy control men without PE. We then analyzed the correlations of plasma leptin and 5-HT levels with the IELT and CIPE-5 scores. The patients with PE were administered sertraline (50mg daily) for 8 weeks, and their plasma leptin and 5-HT levels, CIPE-5 scores and IELT were measured again. Comparative analyses of the data were performed between the experimental and control groups and between the pre- and post-treatment values.
Results |
Plasma leptin levels were significantly higher (P <.0001), whereas plasma 5-HT levels (P <.0001), IELT (P <.0001), and CIPE-5 scores (P <.0001) were significantly lower in the experimental group than in the control group. Significant changes in leptin and 5-HT levels, IELT and CIPE-5 scores were observed after treatment in the experimental group. Plasma leptin levels negatively correlated with 5-HT levels, CIPE-5 scores, and IELT, whereas 5-HT levels positively correlated with IELT and CIPE-5 scores.
Conclusion |
Plasma leptin and 5-HT levels indicate the presence of PE and can be used as diagnostic markers for PE.
Le texte complet de cet article est disponible en PDF.Plan
| Financial Disclosure: The authors declare that they have no relevant financial interests. |
Vol 82 - N° 6
P. 1336-1340 - décembre 2013 Retour au numéro
Article précédent
- Erectile Dysfunction and Fruit/Vegetable Consumption Among Diabetic Canadian Men
- Feng Wang, Sulan Dai, Mingdong Wang, Howard Morrison
- Primary Retroperitoneal Lymph Node Dissection in Low-stage Testicular Germ Cell Tumors: A Detailed Pathologic Study With Clinical Outcome Analysis With Special Emphasis on Patients Who Did Not Receive Adjuvant Therapy
- Hikmat A. Al-Ahmadie, Brett S. Carver, Angel M. Cronin, Semra Olgac, Satish K. Tickoo, Samson W. Fine, Anuradha Gopalan, Jason Stasi, Farhang Rabbani, George J. Bosl, Joel Sheinfeld, Victor E. Reuter
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?